Table 2.
Prevalence of well-controlled asthmaa and long-term control (LTC) asthma medication use among children (0–17 years) and adults (≥18 years) with current asthmab by selected characteristics—Behavioral Risk Factor Surveillance System Asthma Call-back Survey, 2006–2010
| Children: Well-controlled asthma (n = 6163) | Adults: Well-controlled asthma (n = 24 378) | |||||
|---|---|---|---|---|---|---|
| Overall (n = 6163) | Taking LTC medication (n = 2150) | Not taking LTC medication (n = 4013) | Overall (n = 24 378) | Taking LTC medication (n = 8698) | Not taking LTC medication (n = 15 680) | |
| Characteristics | %d (95% CId) | %d (95% CId) | %d (95% CId) | %d (95% CId) | %d (95% CId) | %d (95% CId) |
| Total | 61.6 (59.3–63.2) | 21.9 (20.0–23.9) | 39.7 (37.4–41.9) | 50.0 (49.0–51.0) | 14.8 (14.2–15.5) | 35.2 (34.2–36.2) |
| Sex | ||||||
| Male | 63.5 (60.5–66.4) | 24.7 (22.0–27.7) | 38.8 (35.9–41.8) | 53.1 (51.0–55.1) | 15.3 (14.1–16.7) | 37.8 (35.8–39.8) |
| Female | 59.0 (55.4–62.5) | 18.1 (15.7–20.7) | 41.0 (37.5–44.5) | 48.2 (47.0–49.3) | 14.5 (13.8–15.2) | 33.7 (32.6–34.8) |
| Age, years | ||||||
| 0–4 | 52.7 (46.7–58.8) | 24.6 (19.0–31.2) | 28.2 (23.2–33.7) | NA | NA | NA |
| 5–11 | 62.0 (58.6–65.3) | 24.1 (21.3–27.2) | 37.9 (34.6–41.4) | NA | NA | NA |
| 12–17 | 65.2 (61.6–68.7) | 18.1 (15.8–20.6) | 47.2 (43.7–50.6) | NA | NA | NA |
| 18–34 | NA | NA | NA | 56.9 (54.3–59.4) | 10.2 (8.9–11.7) | 46.6 (44.0–49.2) |
| 35–44 | NA | NA | NA | 52.7 (50.3–55.0) | 14.0 (12.7–15.6) | 38.6 (36.3–40.9) |
| 45–54 | NA | NA | NA | 47.0 (45.3–47.8) | 16.4 (15.1–17.8) | 30.6 (29.0–32.3) |
| 55–64 | NA | NA | NA | 44.5 (42.8–46.1) | 17.1 (15.9–18.4) | 27.4 (25.9–28.9) |
| ≥65 | NA | NA | NA | 42.5 (41.0–44.1) | 20.4 (19.1–21.7) | 22.2 (20.9–23.5) |
| Race/Ethnicitye | ||||||
| White, NH | 62.9 (60.3–65.5) | 24.2 (21.7–26.9) | 38.7 (36.2–41.3) | 50.5 (49.3–51.6) | 15.9 (15.2–16.7) | 34.5 (33.4–35.7) |
| Black, NH | 53.7 (47.0–60.2) | 16.0 (12.1–20.9) | 37.6 (31.8–43.9) | 47.7 (44.1–51.4) | 11.6 (9.7–13.7) | 36.2 (32.7–39.9) |
| Hispanic | 59.0 (51.9–65.9) | 22.2 (16.9–28.7) | 36.8 (30.5–43.7) | 49.8 (44.4–54.1) | 11.4 (9.2–13.9) | 38.4 (34.2–42.8) |
| Other race, NH | 69.3 (62.0–75.7) | 18.2 (13.3–24.5) | 51.0 (42.9–59.1) | 48.7 (44.1–53.4) | 11.6 (9.2–14.2) | 37.2 (32.5–42.2) |
CI, confidence interval; NH, non-Hispanic; NA, not applicable.
Defined as the most impaired level from the one or more individual elements (i.e., daytime and nighttime symptoms in past 30 days and rescue medication use in past 3 months).
Persons who answered “yes” to the questions, “Have you ever been told by a doctor or other health professional that you had asthma?” and “Do you still have asthma?”
Unweighted pooled sample size, 2006–2010. Individual characteristic categories might not sum to total because of item non-response.
Weighted prevalence or 95% CI.
Race categories “white, non-Hispanic” and “black, non-Hispanic” include persons who indicated only a single race group. “Other races, non-Hispanic” includes Asian, American Indian or Alaskan Native, Native Hawaiian and Other Pacific Islander, persons reporting more than one race, and persons reporting their race as something other than those listed here.